C A Stein

Cellular delivery of antisense oligonucleotides.

I Lebedeva, C. Stein, I. Lebedeva, 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Differentiation of immortal cells inhibits telomerase activity.

A. Sartorelli, C. Stein, C A Stein, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Antisense oligonucleotides: basic concepts and mechanisms.

N. Dias, C. Stein, C A Stein, 2002, Molecular cancer therapeutics.

Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine.

M. Caruthers, C. Stein, G. Beaton, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Antisense oligonucleotides: promise and reality.

I Lebedeva, C. Stein, I. Lebedeva, 2001, Annual review of pharmacology and toxicology.

Differential alteration of the anti-HIV-1 effect of phosphorothioate oligonucleotide S-dC28 by AZT, interferon-alpha, and dextran sulfate.

T. Chou, C. Stein, Q. Y. Zhu, 1991, AIDS research and human retroviruses.

Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotides.

N. Dias, C. Stein, C A Stein, 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.